Maxidim Injection 1 gm/vial contains Ceftazidime Pentahydrate, a third-generation cephalosporin antibiotic known for its strong activity against Gram-negative bacteria, including Pseudomonas aeruginosa. It is widely used in the treatment of severe and life-threatening infections, particularly in hospitalized and immunocompromised patients. Maxidim Injection is intended for parenteral administration and should be used under strict medical supervision.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Active Ingredient: Ceftazidime Pentahydrate equivalent to Ceftazidime 1 gm

• Dosage Form: Powder for injection

• Route of Administration: Intravenous or Intramuscular (after reconstitution)

Therapeutic Class

• Third-Generation Cephalosporin Antibiotic

Pharmacology

Ceftazidime is a bactericidal beta-lactam antibiotic that acts by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins, disrupting cell wall formation and leading to bacterial cell death. Ceftazidime is highly resistant to many beta-lactamases and demonstrates potent activity against a broad range of Gram-negative organisms, especially Pseudomonas aeruginosa, along with certain Gram-positive bacteria. Following parenteral administration, it achieves therapeutic concentrations in various body tissues and fluids, including the lungs, urinary tract, skin, bones, joints, and cerebrospinal fluid when meninges are inflamed.

Indications

Maxidim Injection 1 gm/vial is indicated for the treatment of serious infections caused by susceptible organisms, including:

• Lower and upper respiratory tract infections

• Urinary tract infections

• Skin and soft tissue infections

• Bone and joint infections

• Intra-abdominal infections

• Septicemia

• Meningitis

• Hospital-acquired and severe infections in immunocompromised patients

It is also suitable for empirical therapy in severe infections prior to identification of the causative organism.

Dosage and Administration

The dosage and duration of therapy should be determined by the treating physician based on infection severity, patient age, body weight, and renal function.

• Administered intravenously or intramuscularly after proper reconstitution

• Dose adjustment is required in patients with renal impairment

• Therapy duration depends on clinical and microbiological response

Administration should be performed by trained healthcare professionals only.

Benefits and Key Features

• Broad-spectrum antibacterial coverage

• Highly effective against Gram-negative pathogens, including Pseudomonas aeruginosa

• Suitable for severe and hospital-acquired infections

• Rapid and reliable bactericidal action

• Proven clinical efficacy and safety

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Some patients may experience side effects, including:

• Pain or inflammation at the injection site

• Nausea, vomiting, or diarrhea

• Skin rash or hypersensitivity reactions

• Transient changes in liver enzymes or blood counts

Most adverse effects are mild and reversible. Severe allergic reactions are rare but require immediate medical attention.

Precautions and Warnings

• Contraindicated in patients with known hypersensitivity to cephalosporins

• Use with caution in patients with a history of penicillin allergy

• Monitor renal function during prolonged therapy

• Prolonged use may result in superinfection

• Use during pregnancy and breastfeeding only if clearly indicated

Storage

• Store below 30°C in a dry place

• Protect from light

• Reconstituted solution should be used as per manufacturer’s instructions

• Keep out of reach of children

Conclusion

Maxidim Injection 1 gm/vial (Ceftazidime Pentahydrate) is a powerful and dependable antibiotic for the management of severe bacterial infections. With its strong activity against resistant Gram-negative organisms and established clinical performance, it remains an essential option in hospital-based antimicrobial therapy when used appropriately under medical supervision.